Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
metabolic disorder |
| gptkbp:affects |
adults
increasingly children |
| gptkbp:alternativeName |
adult-onset diabetes
non-insulin-dependent diabetes mellitus |
| gptkbp:canBeChronic |
true
|
| gptkbp:causedBy |
insulin resistance
relative insulin deficiency |
| gptkbp:complication |
gptkb:cardiovascular_disease
stroke chronic kidney disease diabetic retinopathy diabetic neuropathy increased risk of infections diabetic foot ulcers |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
| gptkbp:firstDescribed |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
Type 2 Diabetes Mellitus
|
| gptkbp:ICD-10_code |
E11
|
| gptkbp:isNonCommunicable |
true
|
| gptkbp:prevalence |
increasing worldwide
most common form of diabetes |
| gptkbp:prevention |
healthy diet
maintaining healthy weight regular physical activity |
| gptkbp:riskFactor |
gptkb:polycystic_ovary_syndrome
gptkb:gestational_diabetes obesity hypertension physical inactivity older age dyslipidemia family history of diabetes |
| gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst increased hunger slow-healing sores unintended weight loss |
| gptkbp:treatment |
gptkb:metformin
gptkb:DPP-4_inhibitors gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents insulin therapy sulfonylureas |
| gptkbp:bfsParent |
gptkb:D004053
|
| gptkbp:bfsLayer |
7
|